全球首创 以科学为基础 纯素胶原蛋白替代品！
自有品牌/白标胶原蛋白功能食品OEM / ODM
JOIN OUR VeCollal® WEBINAR
The webinar will be held on :
EU Session | April 20, 2022 | 10:00 AM CET
US Session | April 19, 2022 | 03:00 PM PST
It is great honor that Mr. Tony Van Campen, the founder from Vecollal® is with us this time.
- The market has been looking for a plant-based collagen alternative.
- VeCollal® is designed with the environment in mind.
- All of the incredible benefits of collagen with zero animal ingredients.
- How does VeCollal® work?
- In vivo trial will be published in the webinar.
环境变化导致植物基趋势的兴起
近年来，随着消费者开始调整饮食习惯并越来越多地选择纯素食品，植物性趋势经历了爆炸性增长。这种转变的环境、健康和道德原因已广为人知。例如，2018 年全球植物基市场规模为 142 亿美元，预计到 2026 年将达到 314 亿美元，2019 年至 2026 年的复合年增长率为 10.5%。全球纯素健康食品市场预计将从 2019 年的 63 亿美元增长到 2028 年的 167 亿美元，复合年增长率接近 9%。
TCI宣布与VeColal®达成战略联盟
TCI作为VeCollal®的战略合作伙伴，也开发了多款不含动物成分、低碳排放、永续的保健品。
“纯素胶原蛋白补充剂，具有与 I 型人胶原蛋白相同的氨基酸组成。”
Vecollal®与TCI合作，经体外研究证明，可刺激体内成纤维细胞产生胶原蛋白，使胶原蛋白分泌增加134.97%！
非转基因、基于科学、仿生
纯素胶原蛋白补充剂 VeCollal® 是 I 型人胶原蛋白的仿生物，因此具有出色的吸收率和生物相容性。详细的临床试验报告和结果将于2022年上半年发布。这种创新产品确保了纯素产品市场将引领科学清洁美容和纯素胶原蛋白补充剂的新趋势，这将成功影响并显着改善全球消费者的生活。
Highlights of VeCollal® Webinar
There are a wide range of supposed‘vegan collagens’ on the market; but the challenge is in finding a non-GMO, scientifically proven Vegan Solution.
- VeCollal is the world’s first non-GMO, science-based, biomimetic collagen.
- Vecollal has more than 70 clinical research papers to support its efficacy.
- Vecollal is unique because it is the only commercially available non-GMO vegan collagen alternative which is 100% identical to Type I human collagen.
In an in vitro study with TCI, VeCollal® collagen technology stimulated the fibroblasts cells to increase collagen synthesis by approximately 135%. Fiberblasts maintain structural integrity of connective tissues including production of epithelial cells, hence skin and joints.
Detailed clinical trial reports and results will be released in the April of 2022.
GLOBAL TOTAL SOLUTION
We offer solutions across your product formulation development, analytical services and supply globally.